Page last updated: 2024-11-03

probenecid and Brain Vascular Disorders

probenecid has been researched along with Brain Vascular Disorders in 3 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mrsulja, BB1
Mrsulja, BJ1
Spatz, M1
Klatzo, I1
Van Woert, MH1
Weintraub, MI1
Lhoda, F1

Other Studies

3 other studies available for probenecid and Brain Vascular Disorders

ArticleYear
Brain serotonin after experimental vascular occlusion.
    Neurology, 1976, Volume: 26, Issue:8

    Topics: Animals; Cerebral Cortex; Cerebrovascular Disorders; Fenclonine; Gerbillinae; Hydroxyindoleacetic Ac

1976
Predicting the response to levodopa.
    Lancet (London, England), 1971, May-15, Volume: 1, Issue:7707

    Topics: Calcinosis; Capillaries; Central Nervous System; Cerebrospinal Fluid; Cerebrovascular Disorders; Dih

1971
[Clinical aspects of gout].
    Medizinische Monatsschrift, 1970, Volume: 24, Issue:4

    Topics: Allopurinol; Cerebrovascular Disorders; Colchicine; Diagnosis, Differential; Diet Therapy; Female; G

1970